U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218575) titled 'Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations' on Oct. 15.
Brief Summary: The goal of this study is to examine the safety and treatment effects of everolimus in adults and children with PTEN Hamartoma Tumor Syndrome (PHTS) who experience social difficulties. The study will measure if everolimus can safely improve social abilities and functioning in this study population.
PTEN Hamartoma Tumor Syndrome (PHTS) is a genetic condition that results from alteration (germline variant) to the PTEN gene. It is associated with a wide range of symptoms and characteristics, which vary from individual...